New pharmacological approaches for the treatment of alcoholism

  title={New pharmacological approaches for the treatment of alcoholism},
  author={M. Soyka and S. R{\"o}sner},
  journal={Expert Opinion on Pharmacotherapy},
  pages={2341 - 2353}
  • M. Soyka, S. Rösner
  • Published 2006
  • Medicine
  • Expert Opinion on Pharmacotherapy
  • Pharmacological relapse prevention in alcoholism is a rather new clinical field with few drugs being available. Acamprosate, acting predominantly via glutamatergic pathways, and the opioid receptor antagonist naltrexone, were both shown to be efficient in improving rates for continuous abstinence, and not relapsing to heavy drinking in a number of clinical trials and meta-analyses. There are conflicting data on both drugs, especially for acamprosate, according to some recent US studies. However… CONTINUE READING
    35 Citations
    Glutamatergic substrates of drug addiction and alcoholism.
    • 420
    • PDF
    Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision
    • 30
    • PDF
    Baclofen improves abstinence in alcoholic cirrhosis: Still better to come?
    • 7
    Neurobiology, Genetics and Treatment of Alcohol Craving
    • PDF
    Pharmaco-EEG-based assessment of the interaction between ethanol and oxcarbazepine.
    • 4
    • PDF


    Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.
    • 375
    Neuropharmacological treatments for alcoholism: scientific basis and clinical findings
    • 161
    • Highly Influential
    Update on anticonvulsants for the treatment of alcohol withdrawal.
    • 108
    Double-Blind Clinical Trial of Sertraline Treatment for Alcohol Dependence
    • 117
    The use of divalproex in alcohol relapse prevention: a pilot study.
    • 104
    Naltrexone in the treatment of alcoholism.
    • 73
    Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial.
    • 310
    A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence.
    • 123
    Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2.
    • G. A. Kenna, J. McGeary, R. Swift
    • Medicine
    • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
    • 2004
    • 60
    • PDF